生物标志物 生物标志物
Vincent Koppelmans1, Susanne G Mueller2,3, Marit F L Ruitenberg4,5
1University of Utah, Salt Lake City, UT, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
随着阿尔茨海默病 (AD) 的进展,髓密度下降,特别是在更深层的皮质层. 这项研究调查了认知不受损 (CU),轻度认知障碍 (MCI) 和AD受试者的不同大脑区域的髓变化.
科学领域:
- 神经成像是一种神经成像.
- 神经退行发生神经退行.
- 骨髓成像 骨髓成像
背景情况:
- 皮层和皮层下灰质缩是轻度认知障碍 (MCI) 和阿尔茨海默病 (AD) 中神经退行症的特征.
- 这种缩的程度涉及髓质树突的退化仍然在很大程度上是未知的.
- 这项研究研究了在认知不受损 (CU),MCI和AD受试者的皮层深度内的髓密度差异.
研究的目的:
- 评估CU,MCI和AD个体在不同皮层深度上的髓密度差异.
- 探索髓退化和认知状态之间的关系.
主要方法:
- 在71名CU,51名MCI和42名AD受试者身上进行了MP2RAGEMR成像 (1mm同位素分辨率).
- 使用MP2RAGE图像和T1放松图的比率计算髓值,将其投射到皮层深度 (25%,50%,75%).
- 统计分析使用了FMRIB软件库对线性模型的变换分析,对组差异进行了FDR校正.
主要成果:
- 在25%的皮层深度,肌肉质密度在CU中较低,与左半球的MCI受试者相比.
- 在25%和50%的深度,肌密度在CU中较低,而在大多数大脑区域的AD受试者相比.
- 在75%的深度,髓密度在特定区域显示了CU>MCI>AD的趋势,尽管并非所有结果都经过了校正.
结论:
- 髓似乎在更深层的皮质层受到影响最多,从MCI观察到AD的进展.
- 研究结果表明,在晚期阿尔茨海默病或表面层不成比例的缩中,可能会出现补偿性复髓化.
- 源自MP2RAGE的皮质地图可能反映出超出骨髓架构的微观结构变化.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516